Wenjing Xu

2.4k total citations
91 papers, 1.8k citations indexed

About

Wenjing Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenjing Xu has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Wenjing Xu's work include Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (9 papers) and Cancer-related molecular mechanisms research (8 papers). Wenjing Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (9 papers) and Cancer-related molecular mechanisms research (8 papers). Wenjing Xu collaborates with scholars based in China, United Kingdom and United States. Wenjing Xu's co-authors include Yewei Zhang, Qing Xin, Shengli Liu, Xiaochen Dong, Yewei Zhang, Zhencheng Chen, Han Huang, Wenjun Wang, Changyu Cao and Phillip A. Dennis and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Cancer Research.

In The Last Decade

Wenjing Xu

87 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjing Xu China 23 543 427 406 357 354 91 1.8k
Lili Du China 31 819 1.5× 267 0.6× 322 0.8× 417 1.2× 154 0.4× 69 2.5k
Chunyu Zhang China 22 823 1.5× 225 0.5× 403 1.0× 572 1.6× 191 0.5× 118 2.3k
Meng Yang China 25 569 1.0× 275 0.6× 897 2.2× 411 1.2× 239 0.7× 94 2.2k
Ying Long China 30 968 1.8× 386 0.9× 517 1.3× 477 1.3× 249 0.7× 131 2.4k
Xuedong Fang China 30 1.3k 2.4× 438 1.0× 502 1.2× 363 1.0× 188 0.5× 85 2.5k
Reza Akhavan‐Sigari Germany 17 475 0.9× 208 0.5× 353 0.9× 254 0.7× 204 0.6× 86 1.6k
Guan Jiang China 20 804 1.5× 275 0.6× 502 1.2× 162 0.5× 301 0.9× 52 2.0k
Bin Kong China 21 596 1.1× 261 0.6× 420 1.0× 250 0.7× 121 0.3× 47 1.6k
Kun Fang China 28 1.1k 2.0× 195 0.5× 399 1.0× 298 0.8× 167 0.5× 128 2.5k
Zhilong Chen China 26 846 1.6× 206 0.5× 554 1.4× 422 1.2× 485 1.4× 140 2.2k

Countries citing papers authored by Wenjing Xu

Since Specialization
Citations

This map shows the geographic impact of Wenjing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Xu more than expected).

Fields of papers citing papers by Wenjing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Xu. The network helps show where Wenjing Xu may publish in the future.

Co-authorship network of co-authors of Wenjing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjing Xu. A scholar is included among the top collaborators of Wenjing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjing Xu. Wenjing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingfang, et al.. (2026). Cu(I)-doped nitrogen-rich g-C3N4 with enhanced Fenton-like activity for pollutant degradation. Separation and Purification Technology. 390. 136998–136998.
2.
Xu, Wenjing, X. R. Lyu, Yu Chen, et al.. (2025). Investigating preferences and price sensitivity of incentive-based recycling of household waste in emerging megacities. Journal of Environmental Management. 392. 126595–126595. 1 indexed citations
3.
Liu, Shiwei, et al.. (2025). Global research trends on nanotechnology and colorectal cancer: a two-decade analysis. Nanomedicine. 20(4). 343–354. 1 indexed citations
4.
5.
Liu, Jiang, et al.. (2025). Concerned issues and controversies in perioperative immunotherapy for resectable non-small cell lung cancer. Frontiers in Immunology. 16. 1704226–1704226.
6.
7.
Han, S., Yan Jin, Wenjing Xu, et al.. (2023). Neoadjuvant chemoradiotherapy induced lymphopenia in gastric cancer and associations with spleen dosimetry and survival outcomes. Clinical and Translational Radiation Oncology. 40. 100617–100617. 2 indexed citations
8.
Xu, Wenjing, Feifei Wang, Xiao‐Ke Yang, et al.. (2022). Telomere Length and Development of Systemic Lupus Erythematosus: A Mendelian Randomization Study. Arthritis & Rheumatology. 74(12). 1984–1990. 29 indexed citations
9.
Chen, Zhen, Yujie Zhu, Wenjing Xu, et al.. (2022). Pathogenicity of Plesiomonas shigelloides causing mass mortalities of largemouth bass (Micropterus salmoides) and its induced host immune response. Fish & Shellfish Immunology. 132. 108487–108487. 19 indexed citations
10.
Yang, Nan, Hui Li, Changyu Cao, et al.. (2022). Tumor microenvironment-activated theranostic nanoreactor for NIR-II Photoacoustic imaging-guided tumor-specific photothermal therapy. Fundamental Research. 4(1). 178–187. 22 indexed citations
11.
Zhang, Haidong, Hui Dong, Wenjing Xu, et al.. (2022). Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterology. 22(1). 348–348. 9 indexed citations
12.
Xu, Wenjing, Qing Xin, Shengli Liu, et al.. (2022). Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy. Materials Today Bio. 16. 100358–100358. 34 indexed citations
13.
Mi, Chunliu, Kai Ma, Mian Wei, et al.. (2021). Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells. Chemico-Biological Interactions. 351. 109729–109729. 16 indexed citations
14.
Yue, Qi, Ying Liu, Yunfei Zhang, et al.. (2020). A pH ratiometrically responsive surface enhanced resonance Raman scattering probe for tumor acidic margin delineation and image-guided surgery. Chemical Science. 11(17). 4397–4402. 37 indexed citations
15.
Zhang, Qu, Jia Luo, Song Wu, et al.. (2020). Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade. Cancer Discovery. 10(12). 1842–1853. 221 indexed citations
16.
Xu, Wenjing, et al.. (2020). MiR-424 Functions as Potential Diagnostic and Prognostic Biomarker in Melanoma. Clinical Laboratory. 66(07/2020). 9 indexed citations
17.
Han, Limei, Xinwei Li, Cong Wang, et al.. (2019). Surface-Enhanced Resonance Raman Scattering-Guided Brain Tumor Surgery Showing Prognostic Benefit in Rat Models. ACS Applied Materials & Interfaces. 11(17). 15241–15250. 51 indexed citations
18.
19.
Xu, Wenjing, et al.. (2016). EMT influences the expression of CK19 in pleural effusion-derived lung cancer cells and their invasion and metastasis. Oncology Letters. 12(6). 5052–5058. 6 indexed citations
20.
Zhang, Na, Yang Yang, Lin Cheng, et al.. (2012). Combination of Caspy2 and IP-10 Gene Therapy Significantly Improves Therapeutic Efficacy Against Murine Malignant Neoplasm Growth and Metastasis. Human Gene Therapy. 23(8). 837–846. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Du Breakdown of academic impact, for papers by Chunyu Zhang Breakdown of academic impact, for papers by Meng Yang Breakdown of academic impact, for papers by Ying Long Breakdown of academic impact, for papers by Xuedong Fang Breakdown of academic impact, for papers by Reza Akhavan‐Sigari Breakdown of academic impact, for papers by Guan Jiang Breakdown of academic impact, for papers by Bin Kong Breakdown of academic impact, for papers by Kun Fang Breakdown of academic impact, for papers by Zhilong Chen
Rankless by CCL
2026